* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Section ETO (eigth twenty one) Atlas of Genetics and Cytogenetics
Minimal genome wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Protein moonlighting wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Medical genetics wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
X-inactivation wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Gene nomenclature wikipedia , lookup
Primary transcript wikipedia , lookup
Neocentromere wikipedia , lookup
Microevolution wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Genome (book) wikipedia , lookup
Designer baby wikipedia , lookup
Gene expression profiling wikipedia , lookup
Point mutation wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review ETO (eigth twenty one) Jean-Loup Huret Genetics, Department of Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: October 1997 Online version is available at: http://AtlasGeneticsOncology.org/Genes/ETO.html DOI: 10.4267/2042/32043 This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. © 1997 Atlas of Genetics and Cytogenetics in Oncology and Haematology Expression Identity Mainly in the brain; not in hematopoietic cells (debated). Other names: MTG8; CDR (cyclin D related gene); AML1T1 (AML1 translocated to, 1); CBFA2T1 (CBFA2 translocated to, 1) Location: 8q22 Localisation Nuclear (probable). Function Putative transcription factor. Homology 99% identical to the murine homolog. Implicated in ETO (8q22) in normal cells: clone dJ1155L8 - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. Laboratories willing to validate the probes are welcome: contact M Rocchi. t(8;21)(q24;q22)/ANLL → AML1/ETO Disease ANLL, M2 mostly. Prognosis CR is obtained; median survival (1.5-2 yrs) is the range with other ANLL or relatively better. Cytogenetics Additional anomalies are frequent: loss of Y or X chromosome, del(7q)/-7, +8, del(9q); complex t(8;21;Var) are known and have revealed that the crucial event lies on der(8); in agreement with the fact that both genes are transcribed from telomere to centromere. Hybrid/Mutated Gene 5’ AML1 - 3’ ETO. Abnormal Protein N-term AML1 with the Runt domain fused to the nearly entire ETO. Oncogenesis The fusion protein retains the ability to recognize the AML1 concensus binding site (→ negative dominant competitor with the normal AML1) and to dimerize DNA/RNA Transcription From telomere to centromere; alternate slicing at the 5’ end → MTG8A and MTG8B. Protein Protein Diagram Description 577 or 604 amino acids (MTG8A and MTG8B respectively), with a different N-term; 3 proline rich domains (as in transcription factors), 2 of which being also serine and threonine rich (as phosphorylation sites) and 2 Zn fingers (cys.cys/cys.cys and cys.cys/his.cys), a PEST region at the C terminus (conferring rapid intracellular degradation). Atlas Genet Cytogenet Oncol Haematol. 1997;1(2) 46 ETO (eigth twenty one) Huret JL with the cbtb/CBTB subunit → probable altered transcriptional regulation of normal AML1 target genes. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995 Jul 1;86(1):1-14. (Review). References This article should be referenced as such: Huret JL. ETO (eigth twenty one). Atlas Genet Cytogenet Oncol Haematol.1997;1(2):46-47. Ohki M. Molecular basis of the t(8;21) translocation in acute myeloid leukemia. Semin Cancer Biol 1993 Dec;4(6):369-75. (Review). Atlas Genet Cytogenet Oncol Haematol. 1997;1(2) 47